what is alivus life sciences

Alivus Life Sciences Limited is a subsidiary of Nirma Limited, operating as a leading API manufacturer with a focus on specialized, high-value ingredients in key therapeutic segments.

who owns alivus life sciences

Alivus Life Sciences Limited is owned by Nirma Limited, a diversified Indian conglomerate involved in sectors like consumer goods, chemicals, and pharmaceuticals.

Alivus Life Sciences Limited's share price is currently ₹1,067, with a market capitalization of ₹13,087 crore, a P/E ratio of 23.3, book value of ₹246, dividend yield of 0.47%, and a ROCE of 24.9.

Alivus Life Sciences Limited (ALIVUS) Share Price Today — ₹1,050.35

Alivus Life Sciences Limited (ALIVUS) live stock price is ₹1,050.35. Listed on BSE. Sector: Healthcare. Industry: Pharmaceuticals & Biotechnology.

View Alivus Life Sciences Limited stock charts, financial results, quarterly earnings, shareholding pattern, corporate actions, peer comparison and more on Black Bear Labs.

Compare with other stocks in the Healthcare sector.

Use our Stock CAGR Calculator to calculate returns for Alivus Life Sciences Limited. Screen stocks with our Stock Screener.

Learn about key metrics: P/E Ratio, Market Cap, ROE, EPS.

ALIVUS

BSE

Alivus Life Sciences Limited

Healthcare· Pharmaceuticals & Biotechnology· INE03Q201024· Scrip: 543322

EN हिन्दी ગુજરાતી मराठी

₹1,050.35

▲ 10.40 (+0.00%)

2026-04-24

BSE

₹1,050.35

▲ 10.40

+0.00%

243 trading days · 1Y period

TODAY (BSE)

Open1,060.75

High1,061.20

Low1,039.90

Prev Close1,060.75

Volume4,958

Value₹0.5Cr

L: 1,039.90H: 1,061.20

Info

Face Value₹2

Listed2021-08-06

ISININE03Q201024

SeriesA

BSE Scrip543322

Key Metrics

1D

—

1W

—

1M

—

3M

—

6M

—

Valuation

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

Mkt Cap—

Growth (QoQ)

Revenue+26.63%

PAT+43.69%

EPS+43.70%

Profitability

EBITDA Margin31.2%

Net Margin21.3%

TTM EBITDA M.28.7%

TTM Net M.19.4%

Dividend

Yield—

Latest DPS₹5

Payout Ratio44.7%

Growth-77.78%

TTM Revenue

₹2274 Cr

TTM EBITDA

₹652 Cr

TTM PAT

₹442 Cr

TTM EPS

₹36.05

Rev/Share

₹185.3

Quarterly Financials

Revenue

EBITDA

PAT

EPS

Quarter	Revenue	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	642 Cr	467 Cr	200 Cr	185 Cr	137 Cr	₹11.18
2024-09-30	507 Cr	388 Cr	143 Cr	127 Cr	95 Cr	₹7.78
2024-06-30	589 Cr	444 Cr	165 Cr	150 Cr	111 Cr	₹9.10
2024-03-31	537 Cr	410 Cr	144 Cr	130 Cr	98 Cr	₹7.99
2023-12-31	573 Cr	414 Cr	174 Cr	161 Cr	119 Cr	₹9.69
2023-09-30	595 Cr	442 Cr	172 Cr	159 Cr	119 Cr	₹9.69
2023-06-30	578 Cr	398 Cr	195 Cr	182 Cr	135 Cr	₹11.05
2023-03-31	621 Cr	427 Cr	209 Cr	198 Cr	146 Cr	₹11.94

Shareholding Pattern

CURRENT — 2026-03-31

Promoter74.9%

FII5.3%

DII7.3%

Public25.1%

PROMOTER HOLDING TREND

Corporate Actions

Ex-Date	Type	Purpose
2025-09-01	Dividend	Dividend - Rs 5 Per Share
2023-10-17	Dividend	Interim Dividend - Rs 22.50 Per Share
2023-09-22	Other	Annual General Meeting
2023-03-24	Dividend	Interim Dividend - Rs 21 Per Share
2022-09-15	Dividend	Dividend - Rs 10.5 Per Share
2021-11-22	Dividend	Interim Dividend - Rs 10.50 Per Share

Earnings Transcripts

Alivus Life Sciences Limited has informed the Exchange about Schedule of Analyst/Investor meet

14 Nov 2025NSE2K chars

Date	Open	High	Low	Close	Volume
2026-04-24	1,060.00	1,077.95	1,039.70	1,050.05	53,727
2026-04-23	1,053.10	1,096.00	1,052.25	1,061.55	43,072
2026-04-22	1,073.15	1,081.90	1,055.00	1,056.85	29,679
2026-04-21	1,069.35	1,088.00	1,042.25	1,073.15	1.56L
2026-04-20	1,060.00	1,069.95	1,038.75	1,068.05	87,350
2026-04-17	1,071.20	1,079.50	1,060.00	1,069.65	2.15L
2026-04-16	1,061.55	1,084.70	1,050.85	1,071.20	96,087
2026-04-15	1,051.40	1,089.45	1,045.55	1,064.90	1.13L
2026-04-13	1,020.00	1,077.75	1,016.25	1,046.25	1.74L
2026-04-10	1,042.55	1,051.00	1,030.00	1,046.25	54,170
2026-04-09	1,046.00	1,060.10	1,038.85	1,042.55	43,963
2026-04-08	1,054.90	1,054.90	1,010.65	1,044.25	1.04L
2026-04-07	1,005.60	1,042.65	995.00	1,039.80	98,437
2026-04-02	980.00	1,010.00	957.00	989.60	38,758
2026-04-01	994.00	1,013.35	973.05	984.20	86,807
2026-03-27	984.75	1,025.00	973.10	980.80	1.48L
2026-03-25	972.75	1,000.00	969.80	984.75	1.11L
2026-03-24	940.75	976.00	929.50	969.80	70,699
2026-03-20	929.95	954.50	929.70	949.80	53,941
2026-03-19	921.10	937.00	918.35	928.05	54,877
2026-03-18	940.00	984.40	921.90	941.95	99,177
2026-03-17	928.00	942.45	912.60	936.10	74,462
2026-03-16	944.90	947.00	908.35	925.45	54,611
2026-03-13	944.40	947.00	917.45	944.90	97,720
2026-03-12	944.00	946.75	925.30	939.40	25,100
2026-03-11	940.65	957.15	928.70	949.75	93,209
2026-03-10	922.00	946.80	919.75	940.65	42,515
2026-03-09	893.00	930.80	871.20	919.75	68,323
2026-03-06	909.90	919.95	897.60	915.05	62,652
2026-03-05	916.00	916.00	895.05	910.00	27,290

ALIVUS

Key Metrics

Quarterly Financials

Shareholding Pattern

Corporate Actions

Earnings Transcripts

Price History

Frequently Asked Questions

Mutual Fund Holdings